OBJECTIVES: To analyse evidence on the effectiveness of intensive NHS treatments for smoking cessation in helping smokers to quit. METHODS: A systematic review of studies published between 1990 and 2007. Electronic databases were searched for published studies. Unpublished reports were identified from the national research register and experts. RESULTS: Twenty studies were included. They suggest that intensive NHS treatments for smoking cessation are effective in helping smokers to quit. The national evaluation found 4-week carbon monoxide monitoring validated quit rates of 53%, falling to 15% at 1 year. There is some evidence that group treatment may be more effective than one-to-one treatment, and the impact of 'buddy support' varies based on treatment type. Evidence on the effectiveness of in-patient interventions is currently very limited. Younger smokers, females, pregnant smokers and more deprived smokers appear to have lower short-term quit rates than other groups. CONCLUSION: Further research is needed to determine the most effective models of NHS treatment for smoking cessation and the efficacy of those models with subgroups. Factors such as gender, age, socio-economic status and ethnicity appear to influence outcomes, but a current lack of diversity-specific analysis of results makes it impossible to ascertain the differential impact of intervention types on particular subpopulations.
OBJECTIVES: To analyse evidence on the effectiveness of intensive NHS treatments for smoking cessation in helping smokers to quit. METHODS: A systematic review of studies published between 1990 and 2007. Electronic databases were searched for published studies. Unpublished reports were identified from the national research register and experts. RESULTS: Twenty studies were included. They suggest that intensive NHS treatments for smoking cessation are effective in helping smokers to quit. The national evaluation found 4-week carbon monoxide monitoring validated quit rates of 53%, falling to 15% at 1 year. There is some evidence that group treatment may be more effective than one-to-one treatment, and the impact of 'buddy support' varies based on treatment type. Evidence on the effectiveness of in-patient interventions is currently very limited. Younger smokers, females, pregnant smokers and more deprived smokers appear to have lower short-term quit rates than other groups. CONCLUSION: Further research is needed to determine the most effective models of NHS treatment for smoking cessation and the efficacy of those models with subgroups. Factors such as gender, age, socio-economic status and ethnicity appear to influence outcomes, but a current lack of diversity-specific analysis of results makes it impossible to ascertain the differential impact of intervention types on particular subpopulations.
Authors: K J Bough; C Lerman; J E Rose; F J McClernon; P J Kenny; R F Tyndale; S P David; E A Stein; G R Uhl; D V Conti; C Green; S Amur Journal: Clin Pharmacol Ther Date: 2013-03-18 Impact factor: 6.875
Authors: Floor A van den Brand; Gera E Nagelhout; Karin Hummel; Marc C Willemsen; Ann McNeill; Onno C P van Schayck Journal: Tob Control Date: 2018-04-04 Impact factor: 7.552
Authors: Quinn S Wells; Matthew S Freiberg; Robert A Greevy; Rachel F Tyndale; Suman Kundu; Meredith S Duncan; Stephen King; Lesa Abney; Elizabeth Scoville; Dawn B Beaulieu; Vanessa Gatskie; Hilary A Tindle Journal: Nicotine Tob Res Date: 2018-11-15 Impact factor: 4.244
Authors: Scott Mackey; Nicholas Allgaier; Bader Chaarani; Philip Spechler; Catherine Orr; Janice Bunn; Nicholas B Allen; Nelly Alia-Klein; Albert Batalla; Sara Blaine; Samantha Brooks; Elisabeth Caparelli; Yann Ying Chye; Janna Cousijn; Alain Dagher; Sylvane Desrivieres; Sarah Feldstein-Ewing; John J Foxe; Rita Z Goldstein; Anna E Goudriaan; Mary M Heitzeg; Robert Hester; Kent Hutchison; Ozlem Korucuoglu; Chiang-Shan R Li; Edythe London; Valentina Lorenzetti; Maartje Luijten; Rocio Martin-Santos; April May; Reza Momenan; Angelica Morales; Martin P Paulus; Godfrey Pearlson; Marc-Etienne Rousseau; Betty Jo Salmeron; Renée Schluter; Lianne Schmaal; Gunter Schumann; Zsuzsika Sjoerds; Dan J Stein; Elliot A Stein; Rajita Sinha; Nadia Solowij; Susan Tapert; Anne Uhlmann; Dick Veltman; Ruth van Holst; Sarah Whittle; Margaret J Wright; Murat Yücel; Sheng Zhang; Deborah Yurgelun-Todd; Derrek P Hibar; Neda Jahanshad; Alan Evans; Paul M Thompson; David C Glahn; Patricia Conrod; Hugh Garavan Journal: Am J Psychiatry Date: 2018-10-19 Impact factor: 18.112